<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The purpose of this study was to study the association between a parental history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the metabolic profile as well as the presence of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> complications in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: This was a cross-sectional study design in 1,860 patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> from the Finnish Diabetic <z:hpo ids='HP_0000112'>Nephropathy</z:hpo> (FinnDiane) Study (620 patients with and 1,240 age-matched patients without a parental history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>) </plain></SENT>
<SENT sid="2" pm="."><plain>Information on parental history was received from the type 1 diabetic offspring by a standardized questionnaire </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and a positive parental history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had a higher prevalence of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (44 vs. 38%; P = 0.013) and a metabolic profile related to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (higher BMI, larger waist circumference, and higher <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, A1C, and insulin dose per kilogram) and also had a later <z:hpo ids='HP_0003674'>onset</z:hpo> of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (17.2 +/- 9.2 vs. 16.1 +/- 8.9 years; P = 0.008), which was also confirmed in the publicly available <z:mp ids='MP_0002055'>Diabetes</z:mp> Control and Complications Trial data set </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, no association was observed with blood pressure, <z:mp ids='MP_0002055'>diabetes</z:mp> complications, or HLA genotype distribution </plain></SENT>
<SENT sid="5" pm="."><plain>Parental history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was independently associated with age at <z:hpo ids='HP_0003674'>onset</z:hpo> of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (odds ratio 1.02 [95% CI 1.01-1.03]), BMI (1.07 [1.02-1.12]), <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (1.18 [1.03-1.35]), and insulin dose per kilogram (1.63 [1.04-2.54]) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Parental history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with a later <z:hpo ids='HP_0003674'>onset</z:hpo> of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, and a metabolic profile related to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
</text></document>